翻訳と辞書
Words near each other
・ Seroki-Wieś
・ Serokomla
・ Serol Demirhan
・ Serole
・ Serolidae
・ Serolis
・ Serology
・ Seroma
・ Seron
・ Seron (disambiguation)
・ Seronera
・ Seronera Airstrip
・ Seronga
・ Seronga Airport
・ Seronggang
Serono
・ Serooskerke
・ Serooskerke, Schouwen-Duiveland
・ Serooskerke, Walcheren
・ Seropi
・ Seroprevalence
・ Seropédica
・ Serorome River
・ Serositis
・ Serosorting
・ Serostatus
・ Serostim
・ Serotine bat
・ Serotiny
・ Seroto


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Serono : ウィキペディア英語版
Serono

Serono was a biotechnology company headquartered in Geneva, Switzerland. The company was founded as the Serono Pharmacological Institute by Cesare Serono in 1906 in Italy. A key step in its development was the discovery of a method of extracting urinary gonadotropins by Dr Piero Donini allowing the company to become a leader in the supplier of fertility medications, notably Pergonal. Serono was incorporated in 1987 and the holding company, Ares-Serono S.A., changed its name to Serono S.A. in May 2000.
Serono as a stand-alone company develops and markets pharmaceuticals in the fields of Reproductive Health, Multiple Sclerosis, Growth & Metabolism and Dermatology. It is a world-leader in the infertility market with an estimated market share of 60%, making it the third largest biotechnology company in the world. Serono's most important product accounted for 31.6% of the company's sales in 2004.
The eight biotechnology products are available in four core therapeutic areas: neurology for the treatment of relapsing forms of multiple sclerosis, reproductive health for treatments of infertility, dermatology, where Serono has launched biologics in Europe for moderate-to-severe psoriasis, and
growth and metabolism for treatments for HIV-associated wasting and growth deficiencies.
The Company also conducts research in oncology and autoimmune diseases. Through the acquisition in 1997 of GBRI from GlaxoWelcome, becoming its Geneva based research institute named SPRI, and the Manteia Predictive Medicine spin-off, Serono also nursed the emergence of now a commercial leading massive parallel sequencing technology.
==Sale to Merck KGaA==

36% of Serono was sold to Merck KGaA in Sept. 2006 for € 10,6 Billion; Merck KGaA paid CHF 1,100 for each share. The new entity, which merges Serono with Merck's Ethicals division, is called Merck Serono. Its headquarters was in Geneva, within the new Serono facilities. The US operations remain near Boston. The process of merging started in January 2007 after various business regulatory reviews and phases were complete. Until that time, Serono and Merck KGaA operated as separate entities. The new, combined entity, Merck Serono is the size of other large biotechs. In 2011, a decision was made to close the Geneva headquarters and move the headquarters to Darmstadt, Germany resulting in job losses to most of the employees in Geneva.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Serono」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.